Welcome to Prospect! We use the same data as VCs to help you find the best startups and understand what your equity is likely to be worth.
View more companies

Imbue

Imbue is a research company developing Sculptor, a coding agent environment that suggests and generates fixes for code.

Secondary Market Price

Updated: 
Jan 2026
Current Preferred Price
Date:
Sign in to view
Prospect Projected Preferred
Current FMV
Date:
Sign in to view
Prospect Projected FMV
$1.0B
Company Valuation
Updated: 
Jan 2026
AI
Industry
San Francisco, CA
Headquarters
2020
Year Founded
80+
Employee Count

How Imbue Measures Up

To help you manage your Imbue equity, Prospect has run the company through our machine learning model.

Prospect Rating

--

This rating reflects our belief in this company's potential to grow to that many times its current value in 4 years. For an employee with stock, this rating suggests a potential return on equity, but it also comes with some risk.

Exit Risk

--

Our rating is a reflection of the likelihood of this company achieving a liquidity event for its employees based on the quality of investors, funding stage, founders, and more.

Funding Stage

Series B

A company’s funding stage reflects how established it is, how quickly it is scaling, and the average impact an employee may have when joining.

Est val $1.0B
--
Jan 28, 2026

Create a free account to unlock real-time secondary market prices and future projections of Imbue's value.

Sign up to Unlock the Latest Data
Failed to load data. Using sample data.
Loading chart…

Data will be available soon.
Sign up to receive notifications when it is available.

Sign up to get notified
Sign up to Unlock the Latest Data

Prospect Projected Future Imbue Prices

Prospect’s machine learning model has been trained on the same data top-tier investors use to project the likely range of outcomes for Imbue's equity. Create a free account to view 10th-90th percentile projections over 2, 4, and 6 years.

Powerful tools to earn more from your equity

Company Description

Imbue is a research-focused company based in San Francisco, California, that develops AI-powered tools to make software creation accessible. The company's main product is Sculptor, a coding agent environment that suggests and generates code fixes for users in a sandboxed environment. Alongside product development, Imbue conducts research on verifying the correctness of code generated by large language models to ensure reliability. The company is privately held and has completed five funding rounds, the most recent being a Series B round in November 2023 for $12.0 million.

Imbue's future plans center on expanding the accessibility of software creation to a broader audience beyond engineers. Recent announcements highlight this direction, with company representative Kanjun Qiu scheduled to speak at HumanX 2026 on how AI is expanding who builds software. Product updates for Sculptor include new features for security, such as preventing hardcoded API keys, and workflow improvements for managing multiple AI agents. The company has also highlighted use cases outside of traditional software engineering, sharing a testimonial from a philosophy professor who uses Sculptor's multi-agent features for academic research.

Imbue Notable Investors

  • Astera Institute
  • NVIDIA
  • Amazon Alexa Fund
  • Eric Schmidt
  • Kyle Vogt
  • Simon Last
  • Drew Houston
  • Tom Brown
  • Celeste Kidd
  • Tim Hanson
  • Jensen Huang

Imbue Founders

  • Co-Founder, Kanjun Qiu
  • Co-Founder, Josh Albrecht

Peer Group Comparison

Vs Peer Group of >$4B Startups

Frequently Asked Questions

Is Anduril worth joining?

Joining Anduril as an employee is another way to acquire equity, typically through stock options included in compensation packages.

Is Imbue worth joining?

Deciding whether to join a startup like Imbue depends on your personal career goals, risk tolerance, and belief in the company's vision. Tools like Prospect can help you analyze the financial value of your equity offer by projecting its future worth and modeling different scenarios.

What should I do with my Imbue stock?

Managing private company stock involves complex decisions around when to exercise options, plan for taxes, and decide when to sell. Platforms like Prospect offer customized strategies for your equity by analyzing your financial situation and modeling the potential value of your holdings.

Can you sell Imbue stock?

Selling stock in a private company like Imbue is typically possible during specific liquidity events, such as tender offers or secondary market sales, but is often subject to company restrictions. Tools like Prospect can help you navigate these events by determining how much to sell and which shares are the most tax-optimal to offload.

How can I find the value of my Imbue stock?

The value of private stock is often determined by the company's latest 409A valuation, but this doesn't reflect its potential future worth. You can use a platform like Prospect, which uses predictive models trained on proprietary data to forecast your equity's future value.

What is Imbue's equity worth?

A private company's valuation is typically based on the price set during its most recent funding round, but the value of your specific equity depends on many factors. To understand the potential future worth of your holdings, you can use equity management platforms that model various outcomes for your shares.

What is Imbue's stock ticker symbol?

As a private, pre-IPO company, Imbue does not have a stock ticker symbol. Ticker symbols are only assigned to companies once they become publicly traded on a stock exchange.

Can I buy or sell Imbue stock?

As a private company, buying Imbue stock is generally restricted to accredited investors during specific funding rounds or on secondary markets, and opportunities are limited. Selling is typically possible only during company-approved liquidity events, and platforms like Prospect can help you create a strategy for when and how much to sell.

What is the criteria to buy or invest in Imbue stock?

Investing in a private company like Imbue is usually limited to accredited investors, who must meet specific income or net worth requirements as defined by the SEC. Employees often receive equity as part of their compensation without needing to meet these criteria, but purchasing additional shares is a different matter.

Ready to unlock insights on top performing startups?
Ready to unlock insights on top performing startups?